“Bimekizumab Safety in Patients With Psoriasis Achieving Complete Skin Clearance: 4-Year Analysis from 5 Phase 3 3b Trials”. SKIN The Journal of Cutaneous Medicine, vol. 10, no. 2, Mar. 2026, p. s757, https://doi.org/10.25251/v6wwxw80.